SEC 13F Intelligence

Managers / Q2 2019 · view latest →

Melqart Asset Management (UK) Ltd

CIK 0001712901 · 5 ST JAMES'S SQUARE, LONDON, X0, SW1Y 4JU · 00442038264470

Reported Value
$1.5B
Q2 2019
Positions
30
Filings on Record
32
2019–present window
Filed
Aug 14, 2019
original filing

Summary

Melqart Asset Management (UK) Ltd reported $1.5B in U.S.-listed holdings across 30 positions for Q2 2019.

Its largest position, CELG, represents 9.1% of the portfolio.

Compared with Q1 2019, the fund opened 14 new positions and exited 13.

Portfolio Metrics

Turnover
+34.0%
vs prior filed quarter
Top-10 Concentration
+56.4%
share of reported value
Largest Position
+9.1%
Celgene
New / Exited
14 / 13
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $855MQ4 ’18Q1 ’19: $1.1BQ2 ’19: $1.5BQ3 ’19: $1.1BQ4 ’19: $1.2BQ4 ’19Q1 ’20: $1.0BQ2 ’20: $808MQ3 ’20: $900MQ4 ’20: $1.3BQ4 ’20Q1 ’21: $1.5BQ2 ’21: $2.2BQ3 ’21: $2.1BQ4 ’21: $2.0BQ4 ’21Q1 ’22: $1.5BQ2 ’22: $1.3BQ3 ’22: $1.3BQ4 ’22: $1.2BQ4 ’22Q1 ’23: $1.4BQ2 ’23: $1.3BQ3 ’23: $1.4BQ4 ’23: $1.4BQ4 ’23Q1 ’24: $1.6BQ2 ’24: $1.2BQ3 ’24: $1.1BQ4 ’24: $828MQ4 ’24Q1 ’25: $767MQ2 ’25: $700MQ3 ’25: $749MQ4 ’25: $1.0BQ4 ’25Q1 ’26: $1.0Bfilingsflow.com

Portfolio Composition

By security type
Common Stock: 66.7%Other: 28.5%ADR: 4.8%
  • Common Stock · 66.7% · $970M
  • Other · 28.5% · $414M
  • ADR · 4.8% · $70M

Quarter-over-Quarter Changes full breakdown →

vs Q1 2019 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
APC3EURANADARKO PETE CORPNEW+1.57M1.57M+$111M$111M
TSLATESLA INCNEW+410.0K410.0K+$92M$92M
ARRYEURARRAY BIOPHARMA INCNEW+1.28M1.28M+$59M$59M
ZAYO GROUP HLDGS INCNEW+1.80M1.80M+$59M$59M
OXYOCCIDENTAL PETE CORPNEW+1.05M1.05M+$53M$53M
ALLERGAN PLCNEW+278.0K278.0K+$47M$47M
CYEURCYPRESS SEMICONDUCTOR CORPNEW+2.00M2.00M+$44M$44M
NIELSEN HLDGS PLCNEW+1.78M1.78M+$40M$40M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2019

25 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1CELGCELGENE CORPhistory →COM9.13%$133M1.44M
2RHT1EURRED HAT INChistory →COM8.15%$118M630.7K
3NXP SEMICONDUCTORS N VCOM7.77%$113M1.16M
4APC3EURANADARKO PETE CORPhistory →COM7.60%$111M1.57M
5WABCO HLDGS INCCOM4.14%$60M453.5K
6VERSUM MATLS INCCOM4.11%$60M1.16M
7MELLANOX TECHNOLOGIES LTDSHS4.10%$60M538.9K
8ARRYEURARRAY BIOPHARMA INChistory →COM4.09%$59M1.28M
9ZAYO GROUP HLDGS INCCOM4.07%$59M1.80M
10ALLERGAN PLCSHS3.20%$47M278.0K
11CYEURCYPRESS SEMICONDUCTOR CORPhistory →COM3.06%$44M2.00M
12QIWQIWI PLChistory →SPON ADR REP B2.80%$41M2.08M
13NIELSEN HLDGS PLCSHS EUR2.76%$40M1.78M
14FIRST DATA CORP NEWCOM CL A2.72%$40M1.46M
15CONTURA ENERGY INCCOM2.48%$36M694.8K
16TSLATESLA INChistory →COM2.46%$36M160.0K
17ATLANTICA YIELD PLCSHS2.30%$33M1.47M
18TAKEDA PHARMACEUTICAL CO LTDSPONSORED ADS2.00%$29M1.64M
19VRTXVERTEX PHARMACEUTICALS INChistory →COM1.82%$26M144.0K
20AVYAUSDAVAYA HLDGS CORPhistory →COM1.81%$26M2.21M
21TABLEAU SOFTWARE INCCL A1.78%$26M156.0K
22WORKSLACK TECHNOLOGIES INChistory →COM CL A1.55%$23M601.3K
23SPRINT CORPORATIONCOM1.01%$15M2.23M
24QESEURQUINTANA ENERGY SVCS INCCOM0.36%$5M3.29M
25BIDSOTHEBYSCOM0.12%$2M31.2K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$1.0B41May 12, 202613F-HRchanges · EDGAR ↗
Q4 2025$1.0B45Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$749M44Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$700M30Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$767M47May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$828M46Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$1.1B51Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$1.2B54Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$1.6B49May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$1.4B41Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$1.4B35Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$1.3B35Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$1.4B33May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$1.2B40Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$1.3B65Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$1.3B64Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$1.5B69May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$2.0B84Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$2.1B95Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$2.2B107Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$1.5B139May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$1.3B107Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$900M63Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$808M47Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$1.0B39May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$1.2B40Feb 14, 2020RESTATEMENTchanges · EDGAR ↗
Q3 2019$1.1B27Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$1.5B30Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$1.1B32May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$855M21Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.